Cytokine Regulation of Immune Tolerance to Tumors

作者: Ming O. Li , Richard A. Flavell

DOI: 10.1016/B978-012372551-6/50068-7

关键词:

摘要: Publisher Summary Tumors arise from normal self tissues, thus the default pathway to tumor-associated antigens is tolerance—that prevents induction of destructive cellular immune responses. The barriers that prevent antitumor responses are related those inhibit autoimmune diseases, which include mechanisms suppression or deviation under steady state and during wound healing. Cytokines important regulators tolerance tumors. TGF-β most potent pleiotropic regulatory cytokine. Under conditions, inhibits directed at by inhibiting activation differentiation Th1, CTL, NK cells, maintaining peripheral Tregs. This a crucial for tumor tolerance. condition healing, may ensure while promoting healing process. process have critical role in responses, as inflammation associated with invasion resembles

参考文章(134)
Kerstin Steinbrink, Helmut Jonuleit, Gabriele Müller, Gerold Schuler, Jürgen Knop, Alexander H. Enk, Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. ,vol. 93, pp. 1634- 1642 ,(1999) , 10.1182/BLOOD.V93.5.1634
Edna Mozes, Linda Yaswen, Glenn Longenecker, Kunihiro Yoshida, Ashok B. Kulkarni, Anita B. Roberts, Jerrold M. Ward, John James Letterio, Barbara Mittleman, Stefan Karlsson, Shigetoshi Kobayashi, Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse. Journal of Immunology. ,vol. 163, pp. 4013- 4019 ,(1999)
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
Mónica Kurte, Mercedes López, Adam Aguirre, Alejandro Escobar, Juan Carlos Aguillón, Jehad Charo, Christian G Larsen, Rolf Kiessling, Flavio Salazar-Onfray, None, A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells Journal of Immunology. ,vol. 173, pp. 1731- 1737 ,(2004) , 10.4049/JIMMUNOL.173.3.1731
Dmitry I. Gabrilovich, Joyce E. Ohm, Sorena Nadaf, David P. Carbone, Tadao Ishida, Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clinical Cancer Research. ,vol. 5, pp. 2963- 2970 ,(1999)
Vladimir M. Jovasevic, Leonid Gorelik, Jeffrey A. Bluestone, Margalit B. Mokyr, Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity. Journal of Immunology. ,vol. 172, pp. 1449- 1454 ,(2004) , 10.4049/JIMMUNOL.172.3.1449
Peter A. Jones, Stephen B. Baylin, The fundamental role of epigenetic events in cancer Nature Reviews Genetics. ,vol. 3, pp. 415- 428 ,(2002) , 10.1038/NRG816
G Del Prete, M G Giudizi, S Romagnani, M De Carli, R Biagiotti, F Almerigogna, Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. Journal of Immunology. ,vol. 150, pp. 353- 360 ,(1993)